Author

Shuang Liu

Nanjing Drum Tower HospitalORCID 0000-0002-7961-910XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Shuang Liu5 papers · Jinan University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Shuai DingiD· 2 shared Yan LiiD· 2 shared C. Yan ChengiD· 1 shared Chun‐Yi LuiD· 1 shared Daniel HirschhorniD· 1 shared Deshan ReniD· 1 shared Dongquan ShiiD· 1 shared Haiqiao SuniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Shuai DingORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

An Advanced Humanized Systemic Lupus Erythematosus Model Enables Parallel Profiling of B Cell-Targeted Therapies

Rujie Zhu, Shuai Ding, Deshan Ren, Juan Liang, Shuang Liu, Jialu Fan, Shuhua Yu, Zijian Zhang, C. Yan Cheng, K J Wang, Y R Chen, Yang Hang, Xiaoyun Shang, Yan Li, Li Sun

This study develops a humanized SLE model to compare B cell-targeted therapies, finding UCAR-T provides better renal and autoantibody reduction than TCEs despite higher toxicity.

bioRxiv · Jan 29, 2026 · PreprintImmunology

Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression

Wei Liu, Tao Shi, Chun‐Yi Lu, Keying Che, Zijian Zhang, Yuting Luo, Daniel Hirschhorn, Hanbing Wang, Shaorui Liu, Yan Wang, Shuang Liu, Haiqiao Sun, Jun Lü, Yuan Liu, Dongquan Shi, , Yan Li

The paper identifies human myelocyte and metamyelocyte-stage neutrophils as immunosuppressive cells that promote cancer progression and suggests targeting them for immunotherapy.

Cell Research · Jul 15, 2025Peer-reviewedImmunology